I very much doubt the reason it’s won’t be made privately available is due to Pfizer thinking it wouldn’t be worth it. More likely it’s down to sufficient stock being available in the NHS for the cohort that will be receiving it, and the government not wanting to add more demand, which would increase the cost per dose for the NHS.
It’s perverse, but a likely consequence of the Beveridge style universal healthcare system used in the U.K.
The suggestion is to treat the COVID vaccine like the flu vaccine, and make it free for those who need it most, and available to buy for those who don’t. Making it available for sale doesn’t increase costs to the NHS.
I very much doubt the reason it’s won’t be made privately available is due to Pfizer thinking it wouldn’t be worth it. More likely it’s down to sufficient stock being available in the NHS for the cohort that will be receiving it, and the government not wanting to add more demand, which would increase the cost per dose for the NHS.
It’s perverse, but a likely consequence of the Beveridge style universal healthcare system used in the U.K.
The suggestion is to treat the COVID vaccine like the flu vaccine, and make it free for those who need it most, and available to buy for those who don’t. Making it available for sale doesn’t increase costs to the NHS.